The Enterprise Value as of November 2024 (TTM) for Curis, Inc. (CRIS) is 57.30M

According to Curis, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 57.30M. This represents a change of 3.68% compared to the average of 55.27M of the last 4 quarters.

Curis, Inc. (CRIS) Historical Enterprise Value (quarterly & annually)

How has CRIS Enterprise Value performed in the past?

The mean historical Enterprise Value of Curis, Inc. over the last ten years is 184.55M. The current 57.30M Enterprise Value has changed 3.00% with respect to the historical average. Over the past ten years (40 quarters), CRIS's Enterprise Value was at its highest in in the December 2017 quarter at 2.30B. The Enterprise Value was at its lowest in in the March 2020 quarter at 11.72M.

Curis, Inc. (CRIS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Curis, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Curis, Inc. (CRIS) Average Enterprise Value

How has CRIS Enterprise Value performed in the past?

The current Enterprise Value of Curis, Inc. (CRIS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Curis, Inc. (CRIS) Enterprise Value vs. Peers

How is CRIS’s Enterprise Value compared to its peers?

Curis, Inc.’s Enterprise Value is less than Aileron Therapeutics, Inc. (63.85M), greater than Artelo Biosciences, Inc. (1.07M), greater than Histogen Inc. (-3675930.00), greater than Timber Pharmaceuticals, Inc. (-798315.00), greater than X4 Pharmaceuticals, Inc. (20.13M), less than Mereo BioPharma Group plc (540.71M), less than Inozyme Pharma, Inc. (310.02M), less than Terns Pharmaceuticals, Inc. (503.60M), less than Leap Therapeutics, Inc. (62.43M), less than Day One Biopharmaceuticals, Inc. (1.08B), less than PDS Biotechnology Corporation (86.12M), greater than Adaptimmune Therapeutics plc (44.45M), greater than Pieris Pharmaceuticals, Inc. (2.69M), greater than Affimed N.V. (49.39M), less than Corvus Pharmaceuticals, Inc. (553.20M), greater than Aptose Biosciences Inc. (-285247.00),

Build a custom stock screener for Curis, Inc. (CRIS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curis, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Curis, Inc. (CRIS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Curis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.